Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2021

MissionIRNewsBreaks – Augusta Gold Corp. (CSE: G) (OTCQB: AUGG) (FSE: 11B) Secures Conditional Approval for TSX Listing

Posted on March 17, 2021 by MissionIR

Augusta Gold (CSE: G) (OTCQB: AUGG) (FSE: 11B) today announced its receipt of conditional approval to list its common shares on the Toronto Stock Exchange (the “TSX”). Concurrent with the TSX listing, Augusta Gold’s common shares will be de-listed from … Continue reading →

Posted in Augusta Gold Corp. AUGG, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. Announces Another Crime-Fighting Win

Posted on March 17, 2021 by MissionIR

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), today provided an update on another crime-fighting win to add to its long list of successes (see www.Knightscope.com/Crime for others). An article published by the Las … Continue reading →

Posted in Knightscope, Inc. | Leave a comment

MissionIRNewsBreaks – Brain Scientific Inc. (BRSF) Enters Strategic Collaboration with JelikaLite

Posted on March 17, 2021 by MissionIR

Brain Scientific (OTCQB: BRSF), a neurology focused medical device and software company, recently announced a collaboration with JelikaLite, a company developing Cognilum(TM), a non-invasive wearable photobiomodulation device that is being developed to increase the well-being of children living with autism, … Continue reading →

Posted in Brain Scientific Inc. BRSF, MissionIRNewsBreaks | Leave a comment

SRAX Inc.’s (SRAX) Sequire Provides ‘Oil,’ Technology to Significantly Impact Companies’ Interaction with Investors

Posted on March 16, 2021 by MissionIR

Big data is meaningless without technology to unlock, interpret value of information SRAX is on leading edge of offering essential data that can transform publicly held companies Sequire provides key insights that help companies track investors’ behaviors and trends, then … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Releases Q1 Revenue, Gross Profit Numbers

Posted on March 16, 2021 by MissionIR

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has reported its Q1 numbers for the period ending Jan. 31, 2021; the report notes first-quarter … Continue reading →

Posted in Kaival Brands Innovations Group Inc. KAVL, MissionIRNewsBreaks | Leave a comment

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set to Begin Enrolling Brain Cancer Drug Trial Participants

Posted on March 16, 2021 by MissionIR

Brain cancer drug developer CNS Pharmaceuticals is finalizing preparations to begin March enrollment of patients in its potentially pivotal Phase 2 trial evaluating its promising lead candidate, Berubicin, for the overall survival improvement of glioblastoma (“GBM”) patients Glioblastomas are a … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Announces the Beginning of Retail Rollout of Flagship Product

Posted on March 16, 2021 by MissionIR

CPG partner starting TAAT rollout in Ohio, where three-quarters of CROSSMARK accounts indicate interest in carrying the cigarette alternative Company focused on capturing additional market share in $814 billion global tobacco industry CROSSMARK services 100,000-plus convenience stores across the country … Continue reading →

Posted in TAAT Lifestyle & Wellness Ltd. TOBAF | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Upcoming Phase 2b Clinical Trial of Cystic Fibrosis Treatment

Posted on March 16, 2021 by MissionIR

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases, has announced the completion of enrollment for its phase 2b OPTION 2 clinical trial to investigate MS1819 in cystic fibrosis … Continue reading →

Posted in AzurRx BioPharma Inc. AZRX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation Schedule for Upcoming March Investor Conferences

Posted on March 16, 2021 by MissionIR

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, today announced that its Chief Executive Officer, Shawn Singh, … Continue reading →

Posted in VistaGen Therapeutics Inc. VTGN | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Present at Oppenheimer Health Care Conference

Posted on March 16, 2021 by MissionIR

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the Oppenheimer 31st Annual Healthcare Conference. Drysdale’s presentation is … Continue reading →

Posted in Cybin Inc. CLXPF | Leave a comment